Cancer has long been framed as a disease of rogue genes, a story written almost entirely in the language of mutations, checkpoints and clonal evolution. A new review published in Medical Oncology by Fausto Petrelli of ASST Bergamo Ovest and colleagues argues that this picture is incomplete in a way that matters for patients.
Cancer has long been framed as a disease of rogue genes, a story written almost entirely in the language of mutations, checkpoints and clonal evolution.
A new review published in Medical Oncology by Fausto Petrelli of ASST Bergamo Ovest and colleagues argues that this picture is incomplete in a way that matters for patients.
The page is ready to read now. The fuller skim-friendly version will appear here automatically.
Cancer has long been framed as a disease of rogue genes, a story written almost entirely in the language of mutations, checkpoints and clonal evolution. A new review published in Medical Oncology by Fausto Petrelli of ASST Bergamo Ovest and colleagues argues that this picture is incomplete in a way that matters for patients.
Open the app view to save this story, compare related coverage, and continue from the same source.